These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


618 related items for PubMed ID: 19021021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypertension and cognitive function in the elderly.
    Cherubini A, Lowenthal DT, Paran E, Mecocci P, Williams LS, Senin U.
    Am J Ther; 2007; 14(6):533-54. PubMed ID: 18090879
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. From neuronal and vascular impairment to dementia.
    De Deyn PP, Goeman J, Engelborghs S, Hauben U, D'Hooge R, Baro F, Pickut BA.
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():17-24. PubMed ID: 10338104
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cognitive frailty: Predementia syndrome and vascular risk factors.
    Panza F, D'Introno A, Colacicco AM, Capurso C, Parigi AD, Capurso SA, Caselli RJ, Pilotto A, Scafato E, Capurso A, Solfrizzi V.
    Neurobiol Aging; 2006 Jul; 27(7):933-40. PubMed ID: 16023766
    [Abstract] [Full Text] [Related]

  • 11. Senile hypertension and cognitive impairment: an overview.
    Starr JM, Whalley LJ.
    J Hypertens Suppl; 1992 Apr; 10(2):S31-42. PubMed ID: 1593301
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular risk factors and Alzheimer's disease.
    Cechetto DF, Hachinski V, Whitehead SN.
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [Abstract] [Full Text] [Related]

  • 14. Potential for antihypertensive treatment with an AT(1)-receptor blocker to reduce dementia in the elderly.
    Trenkwalder P.
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S71-5. PubMed ID: 12140732
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Arterial hypertension and cognitive decline].
    Leys D, Pasquier F.
    Rev Neurol (Paris); 1999 Aug; 155(9):743-8. PubMed ID: 10528360
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Cognitive decline and hypertension].
    Rigaud AS, Traykov L, Hanon O, Seux ML, Latour F, Lenoir H, Olde-Rikkert M, Forette F.
    Arch Mal Coeur Vaiss; 2003 Jan; 96(1):47-51. PubMed ID: 12613149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.